Literature DB >> 10350493

Oleate salt formation and mesomorphic behavior in the propranolol/oleic acid binary system.

K J Crowley1, R T Forbes, P York, H Nyqvist, O Camber.   

Abstract

Thermal analysis of propranolol/oleic acid mixtures prepared by solvent evaporation enabled construction of the binary system phase diagram. This allowed both physical and chemical interactions to be identified, including complex formation at the equimolar composition. An incongruent melting complex with a characteristic reaction point was identified in excess oleic acid compositions, a common property of fatty acid/fatty acid salt binary systems. The equimolar complex was confirmed to be propranolol oleate using infrared spectroscopy. Wide-angle X-ray powder diffractometry demonstrated that propranolol oleate possessed long-range positional order ( approximately 25 A d spacing) accompanied by a degree of disorder over shorter d spacings. Such a pattern suggested mesophase formation, explaining the unctuous nature of propranolol oleate at room temperature. Accurate measurement of the long-range d spacing was achieved using small-angle X-ray scattering, permitting differentiation of the three different phases identified (phase I: 25.4 A, phase II: 24.6 A, phase III: 25.4-25.5 A). The implications of drug fatty acid salt formation and also mesomorphism in pharmaceutical systems are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350493     DOI: 10.1021/js9804967

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Detection of cocrystal formation based on binary phase diagrams using thermal analysis.

Authors:  Hiroyuki Yamashita; Yutaka Hirakura; Masamichi Yuda; Toshio Teramura; Katsuhide Terada
Journal:  Pharm Res       Date:  2012-08-21       Impact factor: 4.200

2.  Submerged Eutectic-Assisted, Solvent-Free Mechanochemical Formation of a Propranolol Salt and Its Other Multicomponent Solids.

Authors:  Klaudia Bialek; Zaneta Wojnarowska; Marcin Skotnicki; Brendan Twamley; Marian Paluch; Lidia Tajber
Journal:  Pharmaceutics       Date:  2021-12-09       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.